GenoSpace focuses on leveraging biomedical data to enhance the integration of clinical research and clinical care, particularly in the field of oncology. Their technology facilitates personalized medicine by providing tools for clinical trial matching that utilize clinical-genomic patient data. This allows healthcare providers to identify patients eligible for ongoing clinical trials, thereby increasing patient accrual for studies. Additionally, GenoSpace offers an EMR-to-EDC (End-to-End) integration feature that automates the transfer of data from electronic medical records to clinical trial databases, streamlining the data management process and reducing the workload for clinical staff.

Furthermore, GenoSpace provides solutions for study feasibility and site selection, enabling healthcare practices to assess their potential for enrolling patients in new studies based on historical data and competing trials. This data-driven approach empowers oncology practices to make informed decisions about participating in clinical research, ultimately contributing to the advancement of innovative cancer therapies. By connecting clinicians with real-time actionable information and expert guidance, GenoSpace aims to transform the landscape of clinical research and improve patient outcomes in cancer care.

United States

At Genospace, our mission is to deliver the platform that makes biomedical data useful and usable by everyone. Genospace has built a comprehensive platform for precision medicine to enable interpretation, analysis, reporting and collaboration on high-dimensional genomic and other biomedical data. With specific applications supporting research, development, pathology and clinical care, many of the most advanced precision medicine organizations are powered by Genospace. Please visit www.genospace.com for more information.

GenoSpace

Company Details